Sigrid B Sando

Summary

Affiliation: Norwegian University of Science and Technology
Country: Norway

Publications

  1. pmc APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway
    Sigrid B Sando
    Department of Neuroscience, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
    BMC Neurol 8:9. 2008
  2. pmc ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease
    Christopher W Medway
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 9:11. 2014
  3. pmc Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
    Minerva M Carrasquillo
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 6:54. 2011
  4. pmc Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
    Mariet Allen
    Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
    Mol Neurodegener 7:13. 2012
  5. ncbi request reprint Risk-reducing effect of education in Alzheimer's disease
    Sigrid Botne Sando
    Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
    Int J Geriatr Psychiatry 23:1156-62. 2008
  6. ncbi request reprint Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
    Krisztina K Johansen
    Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Parkinsonism Relat Disord 16:307-15. 2010
  7. pmc Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
    John V Pearson
    Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
    Am J Hum Genet 80:126-39. 2007

Collaborators

  • Linda R White
  • Ingvild Saltvedt
  • Stian Lydersen
  • Jan O Aasly
  • Krisztina K Johansen
  • Reinhard Heun
  • Frank Jessen
  • Eric Reiman
  • Michael Hutton
  • Andreas Papassotiropoulos
  • David W Craig
  • Ronald C Petersen
  • Li Ma
  • Fanggeng Zou
  • Maria Barcikowska
  • Dennis W Dickson
  • Steven G Younkin
  • Zbigniew K Wszolek
  • Minerva M Carrasquillo
  • Christopher W Medway
  • Owen A Ross
  • Gina Bisceglio
  • Nilufer Ertekin-Taner
  • Kevin Morgan
  • Mariet Allen
  • Neill R Graff-Radford
  • V Shane Pankratz
  • Julia E Crook
  • John V Pearson
  • Guojun Bu
  • Tynickwa Mims
  • Joanna Siuda
  • Shane Pankratz
  • Neill Graff-Radford
  • Minerva Carrasquillo
  • Samer Abdul-Hay
  • Asha A Nair
  • Christopher P Kolbert
  • Ryan Palusak
  • Sooraj Maharjan
  • Thuy Nguyen
  • Sumit Middha
  • Fariborz Rakhshan
  • Ryan J Uitti
  • Alexandra I Ortolaza
  • Curtis S Younkin
  • High Seng Chai
  • Debra Schultz
  • Kimberly G Malphrus
  • Jin Jen
  • Constantin Georgescu
  • Richard Miles
  • Christopher N Rowley
  • Peter Passmore
  • Gina D Bisceglio
  • Olivia Belbin
  • Talisha A Hunter
  • Marcel Brun
  • Jennifer A Webster
  • Stacey Melquist
  • Makrina Daniilidou
  • Szabolcs Szelinger
  • Rebecca F Halperin
  • Dietrich A Stephan
  • Thomas Beach
  • Waibhav D Tembe
  • Matthew J Huentelman
  • Nils Homer
  • Heike Kolsch
  • Magdalini Tsolaki
  • Keith D Coon
  • Victoria L Zismann

Detail Information

Publications7

  1. pmc APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway
    Sigrid B Sando
    Department of Neuroscience, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
    BMC Neurol 8:9. 2008
    ....
  2. pmc ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease
    Christopher W Medway
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 9:11. 2014
    ....
  3. pmc Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
    Minerva M Carrasquillo
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 6:54. 2011
    ..abstract:..
  4. pmc Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
    Mariet Allen
    Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
    Mol Neurodegener 7:13. 2012
    ..4,617 controls) and PD (678 PDs vs. 712 controls) for association with disease risk (case-controls), age-at-diagnosis (cases) and brain gene expression levels (autopsied subjects)...
  5. ncbi request reprint Risk-reducing effect of education in Alzheimer's disease
    Sigrid Botne Sando
    Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
    Int J Geriatr Psychiatry 23:1156-62. 2008
    ..To estimate the effect of education on the risk of Alzheimer's disease (AD)...
  6. ncbi request reprint Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
    Krisztina K Johansen
    Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Parkinsonism Relat Disord 16:307-15. 2010
    ..However as yet there are no markers that unequivocally distinguish between PDD and DLB...
  7. pmc Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
    John V Pearson
    Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
    Am J Hum Genet 80:126-39. 2007
    ....